Matthew McMillan, MD

Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 2099 - The Impact of the Time of Day of Radiotherapy and Systemic Therapy on Disease Control in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation and Durvalumab

  Sunday, September 29, 2024
  2:45 PM – 4:15 PM ET

• 3044 - A Phase II Trial of Hepatic Ablation of Metastases to Modulate and Enhance Immunotherapy Response (HAMMER) in Non-Small Cell Lung Cancer

  Tuesday, October 1, 2024
  12:45 PM – 2:00 PM ET